Evidence map›Paper›PMID 24067365›Full record

ArticleCell cycle (Georgetown, Tex.)2013

Co-regulation of senescence-associated genes by oncogenic homeobox proteins and polycomb repressive complexes.

Nadine Martin, Selina Raguz, Gopuraja Dharmalingam, Jesús Gil

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Nadine MartinCell Proliferation Group, MRC Clinical Sciences Centre, Imperial College London, London, UK.
Selina Raguz
Gopuraja Dharmalingam
Jesús Gil
Laboratoire de Biologie Cellulaire et Moléculaire du Contrôle de la Prolifération · FRImperial College London · GBMRC Clinical Trials Unit at UCL · GB

Funding

Medical Research Council MC_U120085810
6 · The paper itself

Abstract

Cellular senescence is a stable cell cycle arrest that can be induced by stresses such as telomere shortening, oncogene activation or DNA damage. Senescence is a potent anticancer barrier that needs to be circumvented during tumorigenesis. The cell cycle regulator p16(INK4a) is a key effector upregulated during senescence. Polycomb repressive complexes (PRCs) play a crucial role in silencing the INK4/ARF locus, which encodes for p16(INK4a), but the mechanisms by which PRCs are recruited to this locus as well as to other targets remain poorly understood. Recently we discovered the ability of the homeobox proteins HLX1 (H2.0-like homeobox 1) and HOXA9 (Homeobox A9) to bypass senescence. We showed that HLX1 and HOXA9 recruit PRCs to repress INK4a, which constitutes a key mechanism explaining their effects on senescence. Here we provide evidence for the regulation of additional senescence-associated PRC target genes by HLX1 and HOXA9. As both HLX1 and HOXA9 are oncogenes implicated in leukemogenesis, we discuss the implications that the collaboration between Homeobox proteins and PRCs has for senescence and cancer.

Indexed as

Cell CycleCell LineCell ProliferationCell Transformation, NeoplasticCellular SenescenceCyclin-Dependent Kinase Inhibitor p16FibroblastsGene Expression ProfilingGene Expression RegulationGene SilencingHomeodomain ProteinsHumansPolycomb-Group ProteinsRNA, Small InterferingSignal TransductionTranscription FactorsCyclin-Dependent Kinase Inhibitor p16HLX protein, humanhomeobox protein HOXA9Homeodomain ProteinsPolycomb-Group ProteinsRNA, Small InterferingTranscription FactorscancerHLX1HomeoboxHOXA9p16INK4aPolycombsenescence

Identifiers

PMID24067365
PMCPMC3755069
OpenAlexW2017912063

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.